Tempe-based Clinical Research Advantage, a community-based network of clinical trial sites, was honored with three Silver and two Bronze STEVIE Awards at the 10th Annual American Business Awards held on June 18th in New York City. The American Business Awards are the nation’s premier business awards program. This year, more than 3,000 nominations from organizations of all sizes and in virtually every industry were submitted for consideration in a wide range of categories.
Clinical Research Advantage received the following awards:
- The Silver Award for Company of the Year in the Pharmaceuticals category.
- A Bronze Award for the Fastest-Growing Company of the Year in the Pharmaceuticals category.
- David Bruggeman, CRA’s President and Chief Operating Officer, was honored with Silver Awards for Executive of the Year in both the Pharmaceuticals and the Health Products and Services categories.
- Casey Orvin, CRA’s Vice President of Business Development and Amanda Drake, CRA’s Director of Business Development were honored with a Bronze Award for Management Team of the Year in the Pharmaceuticals Category.
“David Bruggeman, Casey Orvin, Amanda Drake and all of CRA’s employees have made 2012 a remarkable year for our company. Each employee is dedicated to our mission of enhancing patient care by bringing drugs to market more quickly and efficiently, and I would like to congratulate them on achieving this level of recognition from the STEVIE® Awards,” said Mark S. Hanley, CRA’s Chief Executive Officer.
Clinical Research Advantage, Inc. (CRA) is a provider of a range of research services to pharmaceutical companies and clinical research organizations. As a leading trial management organization, CRA operates from 33 sites across 17 geographic markets nationwide, helping trial sponsors bring drugs to market more quickly and efficiently. Founded in 1992, CRA has successfully completed more than 1,800 clinical trials on behalf of its clients. For more information, visit www.crastudies.com.
